Highly Sensitive And Accurate Multiplex Test To Monitor The Immune Response To Viral Infection!
Quanterix is proud to have sponsored this conversation with Powering Precision Health around the capability...
06 June 2020
Webinar Recording: Novel P-tau181 Blood Immunoassay And The Future Of Alzheimer’s Disease Research
Tau phosphorylated at threonine 181 (p-tau181) has been established as a biomarker for Alzheimer’s...
02 April 2020
Panel Discussion: Highly Sensitive And Accurate Multiplex Test To Monitor The Immune Response To Viral Infection!
Learn how Quanterix Simoa technology is providing researchers with the capability to conduct highly...
24 April 2019
at 11:00 AM
Why Industry Leaders Are Choosing The Simoa® Technology For Phase I – IV Clinical Studies
Listen On Demand Join Dr. Maribeth Raines, Vice President of Laboratory Services at Pacific Biomarkers...
12 December 2018
Use Of Simoa Planar Protein Multiplex Arrays As A Sensitive Biomarker Platform In Oncology Clinical Trials
Nature.com Webcasts 8AM PST | 11AM EST | 4PM GMT | 5PM CET Watch On Demand Compared to tissue-based...
19 September 2018
Disrupting Drug Development With Digital Biomarkers And The Power Of Precision Health
Speakers: Kevin HrusovskyPresident, Chairman and CEO Quanterix Corp; Founder, Powering Precision...
21 June 2018
Ultra-sensitive Immunoassays: Beyond Biomarkers And Into PK And Immunogenicity
Speaker: Dan Sikkema, PhD, Vice President Biomarker Services, QuanterixModerator: Dr....
15 May 2018
Ultra-sensitive Detection Of Interferon Alpha Protein In Human Disease By Digital Elisa
Speaker: Dr. Darragh Duffy, Institut Pasteur, ParisModerator: Dr. Jayshan Carpen, Moderator,...
14 September 2017
Predicting Progression Of Neurodegeneration With A Blood Test: How Neurofilament Light Protein May Be A Game-changer For Therapeutic Development In Huntington’s Disease
SIMOA technology has facilitated the quantification of neurofilament light (NfL), a brain-derived protein,...